These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28051255)

  • 1. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer.
    Zhang JJ; Guo SH; Jia BQ
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
    Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
    Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
    Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
    Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells.
    Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G
    J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhang XF; Liu T; Li Y; Li S
    Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the long non-coding RNA SPRY4-IT1 predicts poor prognosis in breast cancer.
    Xiang Y; Chen Y; Shi Y; Wu X; Hao R; Li Q; Li D
    Int J Clin Exp Pathol; 2019; 12(3):1003-1008. PubMed ID: 31933911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
    Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
    Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
    Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
    Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    Zhang J; Lin Z; Gao Y; Yao T
    J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population.
    Ali MA; Shaker OG; Alazrak M; AbdelHafez MN; Khalefa AA; Hemeda NF; Abdelmoktader A; Ahmed FA
    Cancer Biomark; 2020; 28(1):49-63. PubMed ID: 32176630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
    Cui X; Jing X; Long C; Tian J; Zhu J
    Oncotarget; 2017 Mar; 8(12):19049-19056. PubMed ID: 28157702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
    Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
    Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
    Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
    BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.